Association of Immunology and Rheumatology 2nd Middle East Rheumatology Conference 2022

Association of Immunology and Rheumatology 2nd Middle East Rheumatology Conference 2022

Regular price
$20.00
Sale price
$20.00
Regular price
Sold out
Unit price
per 

Association of Immunology and Rheumatology 2nd Middle East Rheumatology Conference 2022

Format: 4 videos, size: 19.3 GB

Course Audience: rheumatologists, allergy & immunology physician

Overview:

Start Date Fri, 12/09/2022 – 08:37

End Date

Event Speciality

Immunology/Allergy

Rheumatology

Organizer GCC Association of Immunology and Rheumatology

Venue Intercontinental Hotel, Festival City, Dubai

Country: United Arab Emirates     City: Dubai

Website

2nd Middle East Rheumatology Conference

Session brief description

2nd Middle East Rheumatology Conference 2022 Dubai United Arab Emirates

Session Start Date

Session End Date

Abstract Submission Deadline

Abstract guidelines

Language:

  • All submitted abstracts must be in English

Author(s):

2nd Middle East Rheumatology Conference 2022 Dubai United Arab Emirates

Building on the success of the first edition, we are certain that the Middle East Rheumatology Conference has now cemented its place as a rewarding scientific experience to our community.

We have planned a three-day comprehensive program with high-level scientific content consisting of interactive educational sessions, workshops, symposiums, abstract presentations and more. This edition is once again taking place in a hybrid format, offering many exciting possibilities to grow your network, transfer knowledge and explore the latest industry developments.

Rheumatological competence relies on scientific knowledge covering the entire field of the rheumatology specialty and the other specialties. Our mission is to expand rheumatology knowledge among rheumatologists, improve early rheumatic cases diagnosis and referral, enhance rheumatology knowledge across other specialties, augment the standard of health care, expand research skills and create scientific evidence, and enable rheumatology experts’ social exchange.

 

 

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

December 9 Hall A (Video MP4 Format)

December 10 Hall A (Video MP4 Format)

December 10 Hall B (Video MP4 Format)

December 11 Hall A (Video MP4 Format)

 

* Detail:

Friday, 9 December 2022

08:00

|

09:00

Registration and Morning Coffee

09:00

|

12:00

Workshop B: Top Tips on Getting Published

Presenters: Prof. Jaap van Laar (Netherlands), Dr. Heather van Epps (UK) & Dr. Puja Mehta (UK)

Hall A

Workshop

12:00

|

12:30

Satellite Symposium by Astra Zeneca

Beyond Covid 19 vaccination.. Tixagevimab and Cilgevimab for the prevention and Treatment of Covid -19

Chair: Dr. Khaled Alnaqbi (UAE)

Speaker: Dr. Dinesh Kharna (USA)

Hall A

Satellite Symposium

  1. 12:00

    Welcome and introduction

    Dr. Khaled Alnaqbi (UAE)

  2. 12:05

    Beyond Covid-19 Vaccination… Tixagevimab and Cilgevimab for the prevention and Treatment of Covid-19

    Dr. Dinesh Kharna (USA)

12:30

|

14:00

Lunch and Friday Prayers

14:00

|

14:30

Satellite Symposium by AbbVie

Rheum Sky

Chair: Martin Lee (UAE)

Speaker: Daniel Ali Taha (Austria)

Hall A

Satellite Symposium

14:30

|

15:20

Opening Ceremony

Hall A

Plenary Sessions

  1. GCC-AIR President Welcome

    Dr. Suad Hannawi (UAE)

  2. Welcome Address

    H.E. Dr. Ahmed Al Saidi (Oman)

  3. Welcome Address

    H.E. Dr. Mariam Al Jalahma (Bahrain)

  4. Welcome Address

    H.E. Dr. Fawaz AlRefaee (Kuwait)

  5. MRC Scientific Chair and Basic Science Chair Welcome

    Dr. Martin Lee (UAE) & Dr. Mahmood Hachim (UAE)

15:20

|

15:30

Coffee & Networking

15:30

|

18:00

Updates from EULAR

Chairs: Dr. Martin Lee (UAE) & Dr. Mahmood Hachim (UAE)

Hall A

Plenary Sessions

  1. 15:30

    Case Based Discussion: Risks and benefits of JAKIs

    Prof. Christopher Edwards (UK)

  2. 15:50

    Case Based Discussion: Difficult to treat RA

    Prof. Jaap van Laar (Netherlands)

  3. 16:10

    Case Based Discussion: ACR Guidelines versus EULAR Recommendations: Are rules there to be broken?

    Prof. Christopher Edwards (UK)

  4. 16:30

    Coffee & Networking

  5. 17:00

    EULAR 2022 Rheumatology Review: Basic science

    Prof. Hendrik Schulze-Koops (Germany)

  6. 17:30

    EULAR 2022 Rheumatology Review: Clinical rheumatology

    Prof. Daniel Aletaha (Austria)

Saturday, 10 December 2022

08:00

|

08:30

Registration and Morning Coffee

08:30

|

09:55

Session I: Rheumatology & Dermatology: Psoriatic Arthritis

Chairs: Dr. Abeer Al Bazali (Kuwait) & Dr. Saadeya Naji (Bahrain)

Hall A

Plenary Sessions

  1. 08:30

    Case Based Interactive Discussion

    Dr. Ahmed Zayat (UAE)

  2. 08:45

    Basic Science: Cytokine signalling in psoriasis and psoriatic arthritis

    Prof. Martin Steinhoff (Qatar)

  3. 09:05

    Psoriasis: Cases in skin of colour

    Dr. Haider Ali (UK)

  4. 09:25

    Keynote Talk: Therapies for psoriatic arthritis which one do I choose?

    Prof. Daniel Aletaha (Austria)

  5. 09:45

    Q&A

08:30

|

10:15

Session I: Paediatric Rheumatology

Chairs: Dr. Elsadeg Sharif (UAE) & Dr. Reem Abdwani (Oman)

Hall B

Pediatric Rheumatology

  1. 08:30

    Familial Mediterranean Fever (FMF)

    Dr. Sima Abu Alsaoud (Palestine)

  2. 09:00

    Deficiency of IL 36 Receptor Antagonist (DITRA)

    Dr. Abdulrahman Al Rasheed (KSA)

  3. 09:30

    Chronic Recurrent Osteomyelitis (CRMO)

    Dr. Kamran Mahmood (UAE)

  4. 10:00

    Q&A

09:55

|

10:15

Coffee & Networking

10:15

|

11:45

Session II: Rheumatology & Pulmonology: Rheumatoid Lung Disease

Chairs: Dr. Adeeba Al Herz (Kuwait) & Dr. Mahmood Hachim (UAE)

Hall A

Plenary Sessions

  1. 10:15

    Case Based Interactive Discussion

    Dr. Mira Merashli (Lebanon)

  2. 10:30

    Basic Science: The pathology of rheumatoid lung disease

    Dr. Maryam Al-Nesf (Qatar)

  3. 10:50

    Local Experience / Guidelines in the GCC / Middle East Region

    Dr. Nuha Alrajhi (KSA)

  4. 11:10

    Keynote Talk: Rheumatoid arthritis and interstitial lung disease

    Dr. Clive Kelly (UK)

  5. 11:30

    Q&A

10:15

|

11:00

Session II: Paediatric Rheumatology

Chairs: Dr. Elsadeg Sharif (UAE) & Dr. Reem Abdwani (Oman)

Hall B

Pediatric Rheumatology

  1. 10:15

    Celiac Disease in Children: Specific Focus on Joints

    Dr. Fawaz Al Refaee (Kuwait)

  2. 10:45

    Q&A

11:00

|

11:30

Session III: Interesting Cases

Chairs: Dr. Elsadeg Sharif (UAE) & Dr. Reem Abdwani (Oman)

Hall B

Pediatric Rheumatology

11:30

|

12:30

Workshop by Amgen

Evenity in the Management of Imminent Risk Patients

Chair: Dr. Hiba Khogali (UAE)

Speaker: Dr. Zaki Abu Zaher (UAE)

Hall B

Workshop

Satellite Symposium

11:45

|

12:15

Satellite Symposium by Novartis

Why do we need a complete treatment approach in PsA

Chair: Pr. Martin Lee (UAE)

Speaker: Dr. Ahmed Zayat (UAE)

Hall A

Satellite Symposium

12:15

|

13:15

Lunch Break

13:15

|

13:45

Satellite Symposium by Lilly

An Evolution in the treatment of SpA

Chair: Dr. Martin Lee (UAE)

Speaker: Prof. Daniel Aletaha (Austria)

Hall A

Satellite Symposium

13:45

|

15:10

Session III: Axial Spondyloarthropathies

Chairs: Dr. Maisam Musgrave (UAE) & Dr. Rajaie Namas (UAE)

Hall A

Plenary Sessions

  1. 13:45

    Case Based Interactive Discussion

    Dr. Martin Lee (UAE)

  2. 14:00

    Basic Science: Role of the Immune System in Arthritis

    Prof. Azzam Magazachi (UAE)

  3. 14:20

    Spondyloarthropathies in the GCC

    Dr. Khalid Alnaqbi (UAE)

  4. 14:40

    Keynote Talk: Management of axial spondyloarthropathies

    Dr. Raj Sengupta (UK)

  5. 15:00

    Q&A

13:45

|

17:45

Clinical Research Background & Methodology

Hall B

Workshop

  1. 13:45

    Clinical Research Background & Methodology

    Mr. Mohamed Mostafa (UAE)

  2. 15:15

    Break

  3. 15:30

    Introduction to ICH-GCP

    Ms. Monika Atanassova (UAE)

  4. 17:30

    Q & A

    Mr. Mohamed Mostafa (UAE) & Ms. Monika Atanassova (UAE)

15:10

|

15:25

Coffee & Networking

15:25

|

16:50

Session IV: Rheumatoid Arthritis

Chairs: Dr. Atheer Alansari (UAE) & Dr. Hanan Al Rayes (KSA)

Hall A

Plenary Sessions

  1. 15:25

    Case Based Interactive Discussion

    Dr. Fahad Fazl (UAE)

  2. 15:40

    Basic Science: An update on rheumatoid pathophysiology

    Prof. Hendrik Schulze-Koops (Germany)

  3. 16:00

    Guidelines for the Management of Rheumatoid Arthritis: Auditing the KSA guidelines

    Dr. Mohammed Omair (KSA)

  4. 16:20

    Keynote Talk: The Brain and Rheumatoid Arthritis

    Prof. Christopher Edwards (UK)

  5. 16:40

    Q&A

16:50

|

17:45

Session V: COVID in Patients with Rheumatic Diseases

Chairs: Dr. Khalid Alnaqbi (UAE) & Dr. Asia Mubashir (UAE)

Hall A

Plenary Sessions

  1. 16:50

    COVID in Patients with Rheumatic Diseases in the Arab World

    Dr. Omar Alsaed (Qatar)

  2. 17:10

    Keynote Talk: COVID in Patients with Rheumatic Diseases: 3 years into the pandemic what have we learnt?

    Dr. Puja Mehta (UK)

  3. 17:30

    Q&A

Sunday, 11 December 2022

09:00

|

10:15

Abstract Presentations

Chairs: Dr. Ahmed Zayat (UAE), Dr. Fahdah Alokaily (KSA) & Dr. Rajaie Namas (UAE)

Hall A

Abstract Presentations

  1. 09:00

    Incidence Of Skin Hyperpigmentation Secondary To Hcq In Emirati Sle Patients, Monocentric Retrospective Cohort Study

    Dr. Hiba Ibrahim Khogali UAE)

  2. 09:10

    Pulmonary Manifestation Of Rheumatoid ArthritisQatar Experience

    Dr. Maryam Ali Y Al-Nesf (Qatar)

  3. 09:20

    The Management Of Bone Health In Breast Cancer Patients On Aromatase Inhibitors

    Dr. Sabahat Ahmed (UK)

  4. 09:30

    Outcomes Of Covid-19 In Inflammatory Rheumatic Diseases: A Retrospective Cohort Study

    Dr. Thamer Alhowaish (KSA)

  5. 09:40

    Consensus Recommendations On The Use Of Biosimilars In The Treatment Of Rheumatic Diseases In The Gulf Region

    Dr. Khalid A. Alnaqbi (UAE)

  6. 09:50

    Rheumatoid Arthritis Patients’ Wide Profile; Clinical Characteristics, Disease Activities, Comorbidities, Laboratory And Subclinical Atherosclerosis

    Dr. Suad Hannawi (UAE)

  7. 10:00

    A Comparison Between The Retention Rate And Side Effects Profile Of Two Jak Inhibitors In Emirati Patients. A Retrospective Real-World Evidence Study

    Dr. Entesar Nuri Etrug (UAE)

  8. 10:10

    Abstract Awards

10:15

|

10:30

Coffee & Networking

10:30

|

12:00

Session VI: Rheumatology & Nephrology: SLE nephritis, lupus and pregnancy

Chairs: Dr. Waleed Hafiz (KSA) & Dr. Mona Alrukhaimi (UAE)

Hall A

Plenary Sessions

  1. 10:30

    Case Based Interactive Discussion

    Dr. Mira Merashli (Lebanon)

  2. 10:50

    Basic Science: Our current understanding of SLE pathophysiology

    Dr. Mahmood Hachim (UAE)

  3. 11:10

    Pregnancy & Lupus

    Dr. Samar Al-Emadi (Qatar)

  4. 11:30

    Management of Lupus Nephritis

    Dr. Reem Al-Jayyousi (UAE)

  5. 11:50

    Q&A

12:00

|

12:30

Satellite Symposium by GSK

Optimizing Therapy in Systemic Lupus Erythematous

Speaker: Atheer Al Ansari (UAE)

Hall A

Satellite Symposium

12:30

|

13:30

Lunch Break

13:30

|

15:05

Session VII: Rheumatology & Endocrinology: Osteoporosis a Multidisciplinary Disease

Chairs: Dr. Aqeel Ghanem (Kuwait) & Prof. Hani Almoallim (KSA)

Hall A

Plenary Sessions

  1. 13:30

    Basic Science: Bone biology and turnover

    Prof. Nandu Goswami (UAE)

  2. 13:45

    GCC Guidelines on Vitamin D Deficiency

    Dr. Yousef Al Saleh (KSA)

  3. 14:00

    GCC Guidelines on the Management of Post-Menopausal Osteoporosis

    Dr. Yousef Al Saleh (KSA)

  4. 14:15

    Secondary Causes of Osteoporosis: A practical approach

    Dr. Asma Al Jaberi (UAE)

  5. 14:30

    Case Based Keynote Talk

    Dr. Thamer Alessa (Kuwait)

  6. 14:50

    Q&A

15:05

|

15:25

Coffee & Networking

15:25

|

16:10

Session VIII: Rheumatology & Orthopaedics Debate: Platelet-RichPlasma injection for knee osteoarthritis

Chair: Dr. Amel Ginawi (UAE)

Hall A

Plenary Sessions

  1. 15:25

    Platelet-Rich-Plasma Injection for Knee Osteoarthritis: The case for: “Benefits for the patient”

    Dr. Ahmed Al Jahwari (Oman)

  2. 15:40

    Platelet-Rich-Plasma Injection for Knee Osteoarthritis: The case against: “It’s just a money making exercise”

    Dr. Marcus Head (UAE)

  3. 15:44

    Q&A

16:10

|

16:15

Closing Remarks

Dr. Suad Hannawi (UAE)